OSE Immunotherapeutics and Boehringer Ingelheim expand colla

OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases

OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , Ingelheim , Rheinland Pfalz , France , Ingelheim Am Rhein , French , Florence Portejoie , Cliver Wood , Kate Barrette , Nicolas Poirier , Melzer Cohen , Linkedin , Veloxis Pharmaceuticals Inc , Boehringer Ingelheim , Animal Health , Nantes University Hospital , International Review Of Cell , Corporate Senior Vice President , Global Head , Discovery Research , Human Pharma , Non Small Cell Lung Cancer , Ulcerative Colitis , Veloxis Pharmaceuticals , Universal Registration Document , Molecular Biology ,